MICHELLE LUNSFORD: Open Payments
NPI 1841353752 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$438 in 17 payments from 10 companies in 2025. Trend: 2023 $2,021 · 2024 $1,909 · 2025 $438
Food & beverage: $438
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $81 |
| AstraZeneca Pharmaceuticals LP | 2 | $73 |
| ABBVIE INC. | 3 | $70 |
| Zimmer Biomet Holdings, Inc. | 1 | $60 |
| UCB, Inc. | 2 | $43 |
| Mallinckrodt Hospital Products Inc. | 1 | $29 |
| Biocon Biologics Inc | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Radius Health, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $15 |
Products named: SAPHNELO, RINVOQ, IntelliCart, Bimzelx, ENBREL, ACTHAR, Yesintek, COSENTYX.
Industry payments across TX — which companies pay providers there.
